Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2013 080 944.5 |
96 | EP file number | EAKZ | 19 21 0117.8 |
97 | EP publication number | EPN | 3656373 |
54 | Designation/title | TI | SPRITZE |
51 | IPC main class | ICM (ICMV) | A61J 9/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61M 5/31 (2006.01), A61M 5/315 (2006.01), A61M 5/28 (2006.01), A61F 9/00 (2006.01), A61K 9/00 (2006.01), A61K 38/17 (2006.01), A61M 5/178 (2006.01), A61P 9/00 (2006.01), A61P 9/10 (2006.01), A61P 27/02 (2006.01), A61P 35/00 (2006.01), A61P 43/00 (2006.01) |
22 | DE application date | DAT | Jan 25, 2013 |
96 | EP application date | EAT | Jan 25, 2013 |
43 | Date of first publication | OT | May 27, 2020 |
| Date of publication of grant | PET | Feb 16, 2022 |
71/73 | Applicant/owner | INH | Novartis AG, Basel, CH |
72 | Inventor | IN | SIGG, Juergen, 4002 Basel, CH; ROYER, Christophe, 4002 Basel, CH; BRYANT, Andrew Mark, 4002 Basel, CH; BUETTGEN, Heinrich Martin, 4002 Basel, CH; PICCI, Marie, 4002 Basel, CH |
| Address for service | | Novartis AG, 4056 BASEL, CH |
66 66
| Domestic priority | PRN PRD
| 202013000688 U Jan 23, 2013
|
66 66
| Domestic priority | PRN PRD
| 202012011016 U Nov 16, 2012
|
66 66
| Domestic priority | PRN PRD
| 202012011260 U Nov 23, 2012
|
66 66
| Domestic priority | PRN PRD
| 202012011259 U Nov 23, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 12189649 Oct 23, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| AU 2012101678 Nov 16, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 12174860 Jul 3, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| AU 2012101677 Nov 16, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 12195360 Dec 3, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| AU 2013100070 Jan 23, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| AU 2013100071 Jan 23, 2013
|
| Due date | FT FG | Jan 31, 2026 Annual fee for the 14th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003656373A1 Searchable text:
EP000003656373A1 Original document:
EP000003656373B1 Searchable text:
EP000003656373B1 |
43 | Date of first publication | EVT | May 27, 2020 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 3, 2025 (Show all update days)(Hide all update days)- Jan 3, 2025
- Nov 27, 2024
- St.36: changed (technical change)
- Aug 8, 2024
- Patent division in charge: changed
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 15.03.2024: changed
- Jul 4, 2024; Jun 27, 2024; Mar 21, 2024; Jan 10, 2024; Jan 4, 2024; Dec 7, 2023; Nov 23, 2023; Jan 11, 2023; Dec 9, 2022; Nov 24, 2022; Mar 10, 2022; Jan 29, 2022; Jan 27, 2022
- Historical data not available for this/these date(s)
- May 27, 2020
- Date of the first transfer into DPMAregister
|